Skip to main content

Strategic Partnership, 2025

Novartis seeks to collaborate with academic institutions to de-risk innovation and bridge the translational gap of early-stage research. They aim to establish long-term relationships with academic scholars who are committed to translating their scientific discoveries into impactful solutions for patients. Novartis offers academic institutions new opportunities for scientific engagement through in-licensing of academic technologies, research collaborations, and co-creation with their scientists, as well as long-term strategic partnerships. Their goal is to work with academic scholars to transform innovative ideas into powerful medicines that will shape the future of healthcare.

Therapeutic Areas:

  • Cardiovascular & Metabolic
  • Oncology
  • Immunology
  • Neuroscience
  • Renal Diseases
  • Cross-Organ Fibrosis
  • Diseases of Aging & Regenerative Medicines

Technology Platforms:

  • Artificial Intelligence (AI)
  • Biologics, Gene Therapies & xRNA
  • Chemistry & Drug Discovery
  • Targeted Delivery & Omics Technologies